Biologics Firm Draws FDA Warning Letter for Unapproved Cellular Products

The FDA has issued a warning letter to a Lake Forest, Calif.-based biologics company, Invitrx Therapeutics, for selling unapproved allogenic cellular-derived drugs, including a human umbilical cord-derived product.
Source: Drug Industry Daily